However, the current conventional method for preoperative assessment of pathological grade and Ki67 labeling index involves minimally invasive percutaneous renal biopsy, which has issues with sampling bias that fail to fully capture tumor heterogeneity and face challenges such as non-repeatability and complications like tumor metastasis. Here, MKI67 is linked to neoplasm.